Evangelista, Luana (2021) Combined Management of Multiple Sclerosis-Related Spasticity. European Journal of Case Reports in Internal Medicine, 8 (Sup 2). pp. 21-22. ISSN 2284-2594
|
Text
Combined Management of Multiple Sclerosis-Related Spasticity.pdf Download (1MB) | Preview |
Abstract
Spasticity is one of the most frequently occurring symptoms associated with multiple sclerosis (MS). Pharmacological therapy and interventional procedures are the main approaches to treatment of MS spasticity. Nabiximols is an oromucosal spray used as an add-on treatment for unresponsive spasticity in patients with MS. The COVID-19 pandemic has had a major impact on the management of patients with chronic neurodegenerative conditions. During this period, many people have had difficulty accessing hospitals or rehabilitation facilities. We report a case that shows the efficacy and tolerability of the combination of pharmacological treatment and neurorehabilitation in the treatment of MS-related spasticity.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Spasticity, multiple sclerosis, nabiximols, neurorehabilitation |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 19 Jan 2022 17:11 |
| Last Modified: | 19 Jan 2022 17:11 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21475 |
Actions (login required)
 |
View Item |
